High-purity, USA-tested, and fully lab ready research peptide designed to target multiple metabolic pathways. It is a double agonist of GLP-1, and GIP, making it a cutting-edge compound in the study of obesity, insulin resistance, and metabolic disorders.

For research purposes only.